Cargando…
p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.
We examined 46 non-small-cell lung carcinomas (NSCLCs) for the presence of p53 mutations in exons 4-9, positive p53 immunostaining and loss of heterozygosity (LOH) in the TP53 locus. p53 mutations were detected in 13 tumour samples (28.3%), whereas overexpression of the p53 protein was found in 30 o...
Autores principales: | Liloglou, T., Ross, H., Prime, W., Donnelly, R. J., Spandidos, D. A., Gosney, J. R., Field, J. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222790/ https://www.ncbi.nlm.nih.gov/pubmed/9099958 |
Ejemplares similares
-
Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck.
por: Field, J. K., et al.
Publicado: (1991) -
Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.
por: Field, J. K., et al.
Publicado: (1996) -
A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material
por: Bediaga, N G, et al.
Publicado: (2013) -
COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer
por: Oleksiewicz, Urszula, et al.
Publicado: (2017) -
Aurora B expression modulates paclitaxel response in non-small cell lung
cancer
por: Al-Khafaji, Ahmed SK, et al.
Publicado: (2017)